Publisher Summary The major urinary metabolite of PGF 1α and PGF 2α in man is 5α,7α-dihydroxy-11-ketotetranorprostane- l, 16-dioic acid (PGF-M). PGF-M is the ideal urinary metabolite to monitor in order to detect changes in biosynthesis of the primary prostaglandins as a group. This chapter discusses the quantitation of the major urinary metabolite of PGF 2α in the human. PGF-M exists as an equilibrium mixture of the dioic acid and the corresponding δ-lactone form. The equilibrium is pH dependent. Quantitative conversion to the δ-lactone form is found to occur after 5 min treatment of the open chain acid at pH 1 and after 1 hr at pH 2, while the rate of lactonization is undetectable at pH 5 over the course of 2 hr at room temperature. The assay described in this chapter is based on stable isotope dilution with quantitative analysis by selected ion monitoring gas chromatography–mass spectrometry. It is important to recognize that the objective in a quantitative analysis of PGF-M is measurement of the total amount of free acid plus δ-1actone in the sample; the proportions present as the free acid or δ-1actone are irrelevant, because this is merely dependent on sample pH.